Sun XQ - Search Results

1

Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.

Li W, Shen LJ, Chen T, Sun XQ, Zhang Y, Wu M, Shu WH, Chen C, Pan CC, Xia YF, Wu PH. Li W, et al. Among authors: sun xq. Chin J Cancer. 2016 Aug 9;35(1):75. doi: 10.1186/s40880-016-0139-6. Chin J Cancer. 2016. PMID: 27507261 Free PMC article.

2

[Radiofrequency ablation combined with systemic chemotherapy in the management of nasopharyngeal carcinoma with liver metastasis].

Li W, Cai GY, Wu M, Shen LL, Sun XQ, Lin CJ, Shi F, Li ZW, Dong AN, Chang BY, Wu PH. Li W, et al. Among authors: sun xq. Zhonghua Yi Xue Za Zhi. 2016 Sep 6;96(33):2629-2634. doi: 10.3760/cma.j.issn.0376-2491.2016.33.006. Zhonghua Yi Xue Za Zhi. 2016. PMID: 27666882 Chinese.

3

Combined CT-guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: Propensity score matching analysis.

Li W, Bai Y, Wu M, Shen L, Shi F, Sun X, Lin C, Chang B, Pan C, Li Z, Wu P. Li W, et al. Oncotarget. 2016 Jul 2;8(32):52132-52141. doi: 10.18632/oncotarget.10383. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881719 Free PMC article.

4

Survival benefits of computed tomography-guided thermal ablation for adrenal metastases from hepatocellular carcinoma.

Lyu N, Kong Y, Pan T, Mu L, Sun X, Li S, Deng H, Lai J, Zhao M. Lyu N, et al. Int J Hyperthermia. 2019;36(1):1003-1011. doi: 10.1080/02656736.2019.1663279. Int J Hyperthermia. 2019. PMID: 31544545 Free article.

5

Follow-up schedule for initial recurrent hepatocellular carcinoma after ablation based on risk classification.

Sun X, Li L, Lyu N, Mu L, Lai J, Zhao M. Sun X, et al. Cancer Imaging. 2020 Jul 1;20(1):42. doi: 10.1186/s40644-020-00319-w. Cancer Imaging. 2020. PMID: 32611383 Free PMC article.

6

Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.

Sun X, Li L, Xu L, Zhou Z, Chen J, Wang J, Zhang Y, Hu D, Chen M. Sun X, et al. BMC Cancer. 2021 Feb 9;21(1):147. doi: 10.1186/s12885-021-07870-0. BMC Cancer. 2021. PMID: 33563246 Free PMC article.

7

Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients.

Sun X, Mei J, Lin W, Yang Z, Peng W, Chen J, Zhang Y, Xu L, Chen M. Sun X, et al. BMC Cancer. 2021 Jul 4;21(1):775. doi: 10.1186/s12885-021-08428-w. BMC Cancer. 2021. PMID: 34218801 Free PMC article.

8

Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection.

Wang JC, Hou JY, Chen JC, Xiang CL, Mao XH, Yang B, Li Q, Liu QB, Chen J, Ye ZW, Peng W, Sun XQ, Chen MS, Zhou QF, Zhang YJ. Wang JC, et al. Among authors: sun xq. Eur J Cancer. 2021 Sep;155:85-96. doi: 10.1016/j.ejca.2021.07.009. Epub 2021 Aug 6. Eur J Cancer. 2021. PMID: 34371445 Free article.

9

Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indications.

Sun X, Zhang Q, Mei J, Yang Z, Chen M, Liang T. Sun X, et al. BMC Cancer. 2022 Mar 19;22(1):293. doi: 10.1186/s12885-022-09405-7. BMC Cancer. 2022. PMID: 35305593 Free PMC article.

10

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation.

Wang Y, Zhang W, Ge H, Han X, Wu J, Sun X, Sun K, Cao W, Huang C, Li J, Zhang Q, Liang T. Wang Y, et al. BMC Cancer. 2023 Jan 25;23(1):86. doi: 10.1186/s12885-023-10550-w. BMC Cancer. 2023. PMID: 36698095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

382 results

Search Page

Filters